162 related articles for article (PubMed ID: 9117791)
1. Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
Trissel LA; Gilbert DL; Martinez JF
Am J Health Syst Pharm; 1997 Jan; 54(1):56-60. PubMed ID: 9117791
[TBL] [Abstract][Full Text] [Related]
2. Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration.
Trissel LA; Martinez JF
Am J Health Syst Pharm; 1996 May; 53(9):1041-5. PubMed ID: 8744467
[TBL] [Abstract][Full Text] [Related]
3. Compatibility of amifostine with selected drugs during simulated Y-site administration.
Trissel LA; Martinez JF
Am J Health Syst Pharm; 1995 Oct; 52(20):2208-12. PubMed ID: 8564592
[TBL] [Abstract][Full Text] [Related]
4. Stability and compatibility of granisetron hydrochloride in i.v. solutions and oral liquids and during simulated Y-site injection with selected drugs.
Mayron D; Gennaro AR
Am J Health Syst Pharm; 1996 Feb; 53(3):294-304. PubMed ID: 8808027
[TBL] [Abstract][Full Text] [Related]
5. Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration.
Trissel LA; Martinez JF
Am J Hosp Pharm; 1994 Jul; 51(14):1792-9. PubMed ID: 7942908
[TBL] [Abstract][Full Text] [Related]
6. Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration.
Trissel LA; Gilbert DL; Martinez JF
Am J Health Syst Pharm; 1997 Dec; 54(23):2708-13. PubMed ID: 9408515
[TBL] [Abstract][Full Text] [Related]
7. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
Trissel LA; Williams KY; Gilbert DL
J Am Pharm Assoc (Wash); 2000; 40(4):515-9. PubMed ID: 10932461
[TBL] [Abstract][Full Text] [Related]
8. Compatibility of Docetaxel with Selected Drugs during Simulated Y-Site Administration.
Trissel LA; Gilbert DL; Wolkin AC
Int J Pharm Compd; 1999; 3(3):241-4. PubMed ID: 23985624
[TBL] [Abstract][Full Text] [Related]
9. Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration.
Trissel LA; Gilbert DL; Martinez JF; Kim MC
Am J Health Syst Pharm; 1997 Oct; 54(19):2192-6. PubMed ID: 9331439
[TBL] [Abstract][Full Text] [Related]
10. Compatibility of filgrastim with selected drugs during simulated Y-site administration.
Trissel LA; Martinez JF
Am J Hosp Pharm; 1994 Aug; 51(15):1907-13. PubMed ID: 7524319
[TBL] [Abstract][Full Text] [Related]
11. Compatibility of aztreonam with selected drugs during simulated Y-site administration.
Trissel LA; Martinez JF
Am J Health Syst Pharm; 1995 May; 52(10):1086-90. PubMed ID: 7656099
[TBL] [Abstract][Full Text] [Related]
12. Compatibility of doripenem with other drugs during simulated Y-site administration.
Brammer MK; Chan P; Heatherly K; Trusley C; Kupiec TC; Trissel LA; Psathas PA; Gilmor T; Schaufelberger D
Am J Health Syst Pharm; 2008 Jul; 65(13):1261-5. PubMed ID: 18574017
[TBL] [Abstract][Full Text] [Related]
13. Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration.
Trissel LA; Gilbert DL; Martinez JF; Baker MB; Walter WV; Mirtallo JM
Am J Health Syst Pharm; 1997 Jun; 54(11):1295-300. PubMed ID: 9179351
[TBL] [Abstract][Full Text] [Related]
14. Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride.
Wu G; Powers D; Yeung S; Chen F; Neelon K
Int J Pharm Compd; 2018; 22(1):86-94. PubMed ID: 29385389
[TBL] [Abstract][Full Text] [Related]
15. Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
Trissel LA; Martinez JF; Simmons M
J Am Pharm Assoc (Wash); 1999; 39(2):141-5. PubMed ID: 10079649
[TBL] [Abstract][Full Text] [Related]
16. Compatibility screening of hextend during simulated y-site administration with other drugs.
Trissel LA; Williams KY; Baker MB
Int J Pharm Compd; 2001; 5(1):69-72. PubMed ID: 23981801
[TBL] [Abstract][Full Text] [Related]
17. Compatibility of gemcitabine hydrochloride with 107 selected drugs during simulated Y-site injection.
Trissel LA; Martinez JF; Gilbert DL
J Am Pharm Assoc (Wash); 1999; 39(4):514-8. PubMed ID: 10467816
[TBL] [Abstract][Full Text] [Related]
18. Compatibility screening of precedex during simulated y-site administration with other drugs.
Trissel LA; Saenz CA; Ingram DS; Williams KY; Retzinger JP
Int J Pharm Compd; 2002; 6(3):230-3. PubMed ID: 23979190
[TBL] [Abstract][Full Text] [Related]
19. Physical and chemical stability of palonosetron hydrochloride with five common parenteral drugs during simulated Y-site administration.
Kupie TC; Trusley C; Ben M; Trissel LA
Am J Health Syst Pharm; 2008 Sep; 65(18):1735-59. PubMed ID: 18769000
[TBL] [Abstract][Full Text] [Related]
20. Incompatibilities of lansoprazole injection with other drugs during simulated y-site coadministration.
Trissel LA; Saenz C; Williams KY; Ingram D
Int J Pharm Compd; 2001; 5(4):314-9. PubMed ID: 23981922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
